Global Hydrogenated Polyisobutene Market Size, Share, and COVID-19 Impact Analysis, Product Type (Emollient, Viscosity Increasing Agent, Plasticizer, and Others), By Application (Lubricants, Additives, Personal Care, Pharmaceuticals, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035

Global Hydrogenated Polyisobutene Market Size Insights Forecasts to 2035

• The Global Hydrogenated Polyisobutene Market Size Was Estimated at USD 2.45 Billion in 2024
• The Market Size is Expected to Grow at a CAGR of around 6.2 % from 2025 to 2035
• The Worldwide Hydrogenated Polyisobutene Market Size is Expected to Reach USD 4.75 Billion by 2035
• Asia Pacific is expected to grow the fastest during the forecast period.

According to a Research Report Published by Spherical Insights and Consulting, The Global Hydrogenated Polyisobutene Market Size was valued at around USD 2.45 Billion in 2024 and is predicted to Grow to around USD 4.75 Billion by 2035 with a compound annual growth rate (CAGR) of 6.2 % from 2025 to 2035. The market for hydrogenated polyisobutene offers substantial prospects in personal care, cosmetics, and pharmaceutical applications because of its outstanding emollient qualities, stability, and growing consumer desire for high-performance, skin-friendly formulations.

Market Overview   

The entire global ecosystem that produces, distributes, and uses hydrogenated polyisobutene (HPIB) is known as the hydrogenated polyisobutene market. Polyisobutene is hydrogenated to produce HPIB, a saturated synthetic hydrocarbon polymer. The procedure improves the polymer's oxidative stability, color neutrality, and sensory characteristics to the point that it can be utilized as an emollient, viscosity modifier, and plasticizer in rubber formulations, adhesives, lubricants, cosmetics, and personal care items. Due to its exceptional emollient, non-greasy, and stable qualities, this chemical has become widely used in pharmaceutical formulations, personal care products, cosmetics, and specialty lubricant applications. Government initiatives, including the U.S. FDA’s bemotrizinol approval and PFAS bans in Connecticut, Maine, and Vermont, are driving hydrogenated polyisobutene adoption as a safer, compliant alternative in cosmetics. The pharmaceutical industry's growth is also driving the market for hydrogenated polyisobutene. Emerging markets and rising consumer knowledge of product ingredients are driving growth in the hydrogenated polyisobutene market.

Report Coverage  

This research report categorizes the hydrogenated polyisobutene market based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the hydrogenated polyisobutene market. Recent market developments and competitive strategies, such as expansion, product launch, development, partnership, merger, and acquisition, have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyzes their core competencies in each sub-segment of the hydrogenated polyisobutene market. 

Driving Factors    

Growth in end-use sectors, including personal care, where it is used as an emollient in lotions and creams, and automotive, where it is used as a lubricant additive, is anticipated to fuel the demand for the hydrogenated polyisobutene market. Key factors driving market growth include the pharmaceutical industry's expansion and the government's growing support for safe ingredients. This growth is primarily driven by the outstanding emollient qualities of the substance and the growing demand for cosmetics and personal care products. The growing use of hydrogenated polyisobutene in the personal care and cosmetics sector is one of the main drivers of hydrogenated polyisobutene market growth.   

Restraining Factors   

The market for hydrogenated polyisobutene is constrained by competing emollients, high production costs, and a shortage of raw materials. Furthermore, uptake in some pharmaceutical and cosmetic applications can be slowed by strict regulatory requirements and formulation compatibility issues.

Market Segmentation      

The hydrogenated polyisobutene market share is classified into product type and application.      

• The emollient segment accounted for the largest share in 2024 and is anticipated to grow at a significant CAGR during the forecast period.             

Based on the product type, the hydrogenated polyisobutene market is divided into emollient, viscosity increasing agent, plasticizer, and others. Among these, the emollient segment accounted for the largest share in 2024 and is anticipated to grow at a significant CAGR during the forecast period. The emollient market is growing as a result of its widespread application in cosmetic and personal care products. It is ideal for products like lip care, moisturizers, sunscreens, and anti-aging creams due to its superior moisturizing qualities, non-greasy texture, and chemical durability. Demand is further fueled by consumers' growing preference for high-performance, skin-friendly ingredients as well as their growing understanding of the safety and effectiveness of products.  

• The personal care segment accounted for the highest market revenue in 2024 and is anticipated to grow at a significant CAGR during the forecast period.        

Based on the application, the hydrogenated polyisobutene market is divided into lubricants, additives, personal care, pharmaceuticals, and others. Among these, the personal care segment accounted for the highest market revenue in 2024 and is anticipated to grow at a significant CAGR during the forecast period.  The desire for high-end skincare and cosmetic products, where hydrogenated polyisobutene is prized for its superior emollient qualities, smooth texture, and non-greasy feel, is the main factor driving the expansion of the personal care category. It improves product efficacy and consumer appeal in a variety of lip care, cream, lotion, and cosmetic formulations.

Regional Segment Analysis of the Hydrogenated Polyisobutene Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the hydrogenated polyisobutene market over the predicted timeframe.   

North America is anticipated to hold the largest share of the hydrogenated polyisobutene market over the predicted timeframe. Growing demand in the cosmetics and personal care sectors, together with strict laws encouraging the use of safer, high-performance ingredients, are the main drivers of the growth in the North American area. Additionally, the use of HPIB in compliant formulations is encouraged by state-level cosmetic standards and the U.S. FDA's approval of novel sunscreen agents. The U.S. FDA's December 29, 2025, research investigating per- and polyfluoroalkyl substances (PFAS) in cosmetics, which identifies data gaps and causes prohibitions in 11 states effective 2026, accelerates the adoption of HPIB as a safer, PFAS-free alternative.

Asia Pacific is expected to grow at a rapid CAGR in the hydrogenated polyisobutene market during the forecast period. The market is expanding due in large part to rising disposable incomes, growing consumer knowledge of the benefits of skincare, and rising demand for novel, safe, and high-quality formulations. The need for high-end, multipurpose skincare products is rising in nations like China, Japan, South Korea, and India, which presents substantial chances for HPIB adoption. In addition to the December 12, 2025, call for 2026 Cosmetic Standard Projects, China's National Medical Products Administration (NMPA) December 2025 instructions restructuring cosmetics rules to prioritize innovation and non-animal testing, improve HPIB incorporation in compliant formulations.   

Competitive Analysis:      

The report offers the appropriate analysis of the key organizations/companies involved within the hydrogenated polyisobutene market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.    

List of Key Companies

• A&E Connock
• BASF SE
• Elementis PLC
• Glenn Corporation
• Henan Tianfu Chemical Co., Ltd
• INEOS Oligomers
• NOF America Corporation
• Sensient Cosmetic Technologies
• SOPHIM
• The Innovation Company
• UPI Chem
• Others  

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment  

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the hydrogenated polyisobutene market based on the below-mentioned segments: 

Global Hydrogenated Polyisobutene Market, By Product Type

• Emollient
• Viscosity Increasing Agent
• Plasticizer
• Others

Global Hydrogenated Polyisobutene Market, By Application

• Lubricants
• Additives
• Personal Care
• Pharmaceuticals
• Others

Global Hydrogenated Polyisobutene Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico

• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific

• South America
  • Brazil
  • Argentina
  • Rest of South America

• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa